胰腺癌综合诊治方法中国专家共识.ppt

［31］ Takahara N，Isayama H，Nakai Y，et al． A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with re- fractory pancreatic cancer［J］． Cancer Chemother Pharmacol， 2013，72(5):985 －990． ［32］ Wang J，Xia TY，Wang YJ，et al． Long-term results of gamma ray-based stereotacitc body radiation therapy in treatment of medi- cally unfit or inoperable non-metastatic pancreatic adenocarcino- ma［J］． Int J Ｒadiat Oncol Biol Phys，2012，84(Suppl 3):815 －816． ［33］ 李 光，于洋洋，韩 冲，等． 81 例胰腺癌后程加量三维适 形放疗的疗效分析［J］． 中国医科大学学报，2012，41(12): 1134 －1143． ［34］ Chang D，Xia T，Li P，et al． Promising clinical outcome of ster- eotactic body radiation therapy for limited pancreatic carcinoma ［J］． Int J Ｒadiat Oncol Biol Phys，2010，78(3):307． ［35］ 常冬姝，夏廷毅，李 平，等． 全身 γ 刀治疗局限期胰腺癌 临床结果分析［J］． 中华放射肿瘤学杂志，2009，18(6):470 －473． ［36］ Xia T，Li HQ，Wang J，et al． Clinical outcome of hypofraction- ated radiation therapy for lung，liver，and pancreatic cancer［J］． Int J Ｒadiat Oncol Biol Phys，2010，78(Suppl 3):574 －575． ［37］ Stocken DD，Buchler MW，Dervenis C，et al． Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer［J］． Br J Cancer，2005，92(8):1372 －1381． ［38］ Kleeff J，Michalski CW，Friess H，et al． Surgical treatment of pancreatic cancer: the role of adjuvant and multimodal therapies ［J］． Eur J Surg Oncol，2007，33(7):817 －823． ［39］ Garofalo MC，Ｒegine WF，Tan MT，et al． On statistical reanaly- sis，the EOＲTC trial is a positive trial for adjuvant chemoradi- ation in pancreatic cancer［J］． Ann Surg，2006，244(2):332 － 333． ［40］ Gastrointestinal Tumor Study Group． Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer［J］． Cancer，1987，59(12):2006 －2010． ［41］ Ｒegine WF，Winter KA，Abrams ＲA，et al． Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial［J］． JAMA，2008，299(9):1019 － 1026． ［42］ Van Laethem JL，Hammel P，Mor